The New York Entrepreneur

Coronavirus tally: U.S. death toll tops 935,000 and FDA reportedly reviewing second booster shot

Read Time:1 Minute, 14 Second

The U.S. COVID death toll climbed to 935,991 on Tuesday, according to data aggregated by Johns Hopkins University, and the Wall Street Journal said U.S. regulators are now reviewing offering a fourth booster shot. The review is in its early stages and will depend on data and whether it would be needed for all groups or only those most at risk. The news comes as UK Prime Minister Boris Johnson prepares to drop all COVID restrictions in England, including the requirement to self-isolate after testing positive, against the advice of scientists. Hong Kong, by contrast, is ordering mandatory testing for all residents, as the Associated Press reported. The U.S.
is averaging about 89,024 cases of COVID a day, down 65% from two weeks ago,according to a New York Times tracker, as the surge of cases caused by the highly infectious omicron variant continues to decline from its January peak. The U.S. is averaging 65,861 hospitalizations a day, down 43% from two weeks ago. And deaths are finally starting to fall, down 19% to an average of 2,096 a day.
Globally, the case tally now stands at 426.1 million while the death toll is above 5.95 million. The U.S. continues to lead the world with 78.5 million cases.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

About Post Author

Happy
Happy
0 %
Sad
Sad
0 %
Excited
Excited
0 %
Sleepy
Sleepy
0 %
Angry
Angry
0 %
Surprise
Surprise
0 %
Previous post Tempur Sealy stock slumps toward 9-month low after profit, sales miss expectations as costs jumped
Next post Need to Know: Russia-Ukraine conflict is a worry, but this is still the biggest threat for stock investors, says JPMorgan